Cocaine pp 81-114 | Cite as

The Clinical Manifestions of Cocaine Abuse

  • Mark S. Gold
Part of the Drugs of Abuse book series (DOAC, volume 3)


The clinician’s task of diagnosing cocaine abuse is significantly complicated by the common tenacity of drug users in denying their drug consumption. A drug user’s denial is fueled in part by the stigma society attaches to drug use and by the fact that admission of drug use threatens the continuation of the drug-using state. As a result, patient histories are a notoriously unreliable means of identifying drug use. Figure 4.1, derived from an antenatal and postpartum study of inner-city black mothers, illustrates the underreporting of contemporaneous drug use. In this study, drug use was assessed by interviews during pregnancy and 13 months after giving birth. The findings of this study that drug use during pregnancy was significantly underreported confirm other studies of different populations.1


Eating Disorder Cocaine Abuse Cocaine User Cocaine Administration Intravenous Cocaine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jacobson SW, Jacobson JL, Sokol RJ, et al. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol. 1991;13:535–540.PubMedCrossRefGoogle Scholar
  2. 2.
    Wallach MB, Gerson S. A neuropsychopharmacological comparison of d-amphetamine, L-dopa and cocaine. Neuropharmacology. 1971;10:743.PubMedCrossRefGoogle Scholar
  3. 3.
    Dimijian GG. Contemporary drug abuse. In: Goth A, ed. Medical Pharmacology, Principles and Concepts. 7th ed. St. Louis: CV Mosby Co; 1974:313.Google Scholar
  4. 4.
    Sterk C. Cocaine and HIV seropositivity. Lancet. 1988;1:1052–1053.PubMedCrossRefGoogle Scholar
  5. 5.
    Dackis CA, Gold MS. Biological aspects of cocaine addiction. In: Volkow ND, ed. Cocaine in the Brain. Houston: Rutgers University Press; 1988.Google Scholar
  6. 6.
    Mule SJ. The pharmacodynamics of cocaine abuse. Psychiatric Ann. 1984;14(10):724–727.Google Scholar
  7. 7.
    Gold MS, Verebey K. The psychopharmacology of cocaine. Psychiatric Ann. 1984;14(10):714–723.Google Scholar
  8. 8.
    Gawin FH, Ellinwood EH Jr. Cocaine and other stimulants. N Engl J Med. 1988;318(18):1173–1182.PubMedCrossRefGoogle Scholar
  9. 9.
    Weinstein SP, Gottheil E, Smith RH, Migrala KA. Cocaine users seen in medical practice. Am J Drug Alcohol Abuse. 1986;12:341–354.PubMedCrossRefGoogle Scholar
  10. 10.
    Jeri FR, Sanchez CC, Del Pozo T, Fernandez M, Carbajal C. Further experience with the syndromes produced by coca paste smoking. In: Jeri FR, ed. Cocaine 1980. Lima, Peru: Pacific Press; 1980.Google Scholar
  11. 11.
    Jaffee JH. Drug addiction and drug abuse. In: Goodman AG, Gilman LS, eds. The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan; 1985:532–581.Google Scholar
  12. 12.
    Anthony JC, Tien AY, Petronis KR. Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol. 1989; 129(3) 543–549.PubMedGoogle Scholar
  13. 13.
    Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry. 1986;43:107–113.PubMedCrossRefGoogle Scholar
  14. 14.
    Marzuk PM, Tardiff K, Leon AC, Stajic M, Morgan EB, Mann JJ. Prevalence of recent cocaine use among motor vehicle fatalities in New York City JAMA. 1990;263(2):250–256.PubMedCrossRefGoogle Scholar
  15. 15.
    Novick DM. The medically ill substance abuser. In: Lowinson JH, et al. eds. Substance Abuse: A Comprehensive Textbook. Baltimore, Md: Williams & Wilkins; 1992:chap 50.Google Scholar
  16. 16.
    Benchimol A, Bartall H, Desser KB. Accelerated ventricular rhythm and cocaine abuse. Ann Intern Med. 1978;88:519–520.PubMedGoogle Scholar
  17. 17.
    Karch SB, Billingham ME. The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med. 1988;112(3):225–230.PubMedGoogle Scholar
  18. 18.
    Crumb WJ Jr, Clarkson CW. Characterization of cocaineinduced block of cardiac sodium channels. Biophys J. 1990: 57(3)589–599.PubMedCrossRefGoogle Scholar
  19. 19.
    Jones LF, Tackett RL. Central mechanisms of action involved in cocaine-induced tachycardia. Life Sci. 1990;46(10):723–728.PubMedCrossRefGoogle Scholar
  20. 20.
    Perez-Meyes M, DiGuiseppi S, Ondrusek G, Jeffcoat AR, Cook CE. Free-base cocaine smoking. Clin Pharmacol Ther. 1982;32:459–465.CrossRefGoogle Scholar
  21. 21.
    Foltin RW, Fischman MW, Pedroso JJ, Pearlson GD. Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend. 1988;22:169–177.PubMedCrossRefGoogle Scholar
  22. 22.
    Lichtenfeld PJ, Rubin DB, Feldman RS. Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol. 1984;41:223–224.PubMedCrossRefGoogle Scholar
  23. 23.
    Fredericks RK, Lefkowitz DS, Challa VR, Troost BT. Cerebral vasculitis associated with cocaine abuse. Stroke. November 1991;22(11):1437–1439.PubMedCrossRefGoogle Scholar
  24. 24.
    Smith HWB, Lieberman HA, Brody SL, Battey LL, Donohue BC, Morris DC. Acute myocardial infarction temporally related to cocaine use. Ann Intern Med. 1987;107:13–18.PubMedGoogle Scholar
  25. 25.
    Vitullo JC, Karam R, Mekhail N, Wicker P, Engelmann A, Khairallah PA. Cocaine-induced small vessel spasm in isolated rat hearts. Am J Pathol. 1989;135(1):85–91.PubMedGoogle Scholar
  26. 26.
    Isner HM, Estes NAM III, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438–1443.PubMedCrossRefGoogle Scholar
  27. 27.
    Amin M, Gabelman G. Cocaine and chest pain. Ann Intern Med. 1992;116(1):91. Letter.PubMedGoogle Scholar
  28. 28.
    Wilkerson RD. Cardiovascular toxicity of cocaine. In: Clouet D, Asghar K, Brown R, eds. Natl Inst Drug Abuse Res Monogr Ser. 1988;88:304–324.Google Scholar
  29. 29.
    Nadamanee K, Gorelick DA, Josephson MA, et al. Myocardial ischemia during cocaine withdrawal. Ann Intern Med. 1989;111(11):876–880.Google Scholar
  30. 30.
    Schachne JS, Roberts BH, Thompson PD. Coronary-artery spasm and myocardial infarction associated with cocaine use. N Engl J Med. 1984;310:1665–1666.PubMedCrossRefGoogle Scholar
  31. 31.
    Dressier FA, Malekzadeh S, Roberts WC, et al. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. JAMA. 1990;263(23):3197.CrossRefGoogle Scholar
  32. 32.
    Togna G, Tempesta E, Togna AR, Doci N, Cebo B, Caprino I. Platelet responsiveness and biosynthesis of thromboxane prostacyclin in response in in vitro cocaine treatment. Haemostasis. 1985;15:100–107.PubMedGoogle Scholar
  33. 33.
    Peng SK, French WJ, Pelikan PCD. Direct cocaine cardiotoxicity demonstrated by endomyocardial biopsy. Arch Pathol Lab Med. 1989;113(8):842–845.PubMedGoogle Scholar
  34. 34.
    Wiener MD, Putnam CE. Pain in the chest in a user of cocaine. JAMA. 1987;258(15):2087–2088.PubMedCrossRefGoogle Scholar
  35. 35.
    Itkonen J, Schnoll A, Glassroth J. Pulmonary dysfunction in “freebase” cocaine users. Arch Intern Med. 1984;144:2195–2197.PubMedCrossRefGoogle Scholar
  36. 36.
    Hoffman CK, Goodman PC. Pulmonary edema in cocaine smokers. Radiology. 1989; 172(2):462–465.Google Scholar
  37. 37.
    Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315:1495–1500.PubMedCrossRefGoogle Scholar
  38. 38.
    Murray RJ, Albin RJ, Mergner W, et al. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest. 1988;427–429Google Scholar
  39. 39.
    Rebhum J. Association of asthma and freebase smoking. Ann Allergy. 1988;60(4):339–342.Google Scholar
  40. 40.
    Jonsson S, O’Meara M, Young JB. Acute cocaine poisoning: importance of treating seizures and acidosis. Am J Med. 1983; 75:1061–1064.PubMedCrossRefGoogle Scholar
  41. 41.
    Barden JC. Crack smoking seen as a peril to the lungs. New York Times. December 24, 1989:19.Google Scholar
  42. 42.
    Byck R. Cocaine Papers: Sigmund Freud. New York: Stonehill Publishing Co; 1974.Google Scholar
  43. 43.
    Merriam AE, Medalia A, Levine B. Partial complex status epilepticus associated with cocaine abuse. Biol Psychiatry. 1988;23:515–518.PubMedCrossRefGoogle Scholar
  44. 44.
    Post RM, Kopanda RT, Black KE. Progressive effects of cocaine on behavior and central amine metabolism in the rhesus monkey: relationship to kindling and psychosis. Biol Psychiatry. 1976;11:403–419.PubMedGoogle Scholar
  45. 45.
    Estroff TW, Gold MS. Chronic medical complications of drug abuse. Psychiatric Med. 1987;3(3):267–286.Google Scholar
  46. 46.
    Ashley R. Cocaine: Its History, Uses and Effects. New York: St. Martin’s Press; 1975:240.Google Scholar
  47. 47.
    Siegel RK. Cocaine smoking. J Pyschoactive Drugs. 1982;14:277–359.Google Scholar
  48. 48.
    Smith DE, Wesson DR, Apter-Marsh M. Cocaine-and alcoholinduced sexual dysfunction in patients with addictive diseases. J Psychoactive Drugs. 1984;16:359–361.PubMedCrossRefGoogle Scholar
  49. 49.
    Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666–669.PubMedCrossRefGoogle Scholar
  50. 50.
    Centers for Disease Control. HIV/AIDS surveillance: AIDS cases reported through September 1989. Washington, DC: U.S. Department of Health and Human Services, Public Health Service; October 1989.Google Scholar
  51. 51.
    Mendelson J, Teoh S, Lange U, Mello N, Weiss R, Skupny A. Hyperprolactinemia during cocaine withdrawal. In: Harris LS, ed. Natl Inst Drug Abuse Res Monogr Sr. 1988;81:67–73.Google Scholar
  52. 52.
    Jonas JM, Gold MS. Cocaine abuse and eating disorders. Lancet. 1986;1:390–391.PubMedCrossRefGoogle Scholar
  53. 53.
    Ritchie JM, Greene NM. Local anesthetics. In: Gilman AG, Goodman LS, Rall TW, et al., eds. The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan; 1985:309–310.Google Scholar
  54. 54.
    Roberts DCS, Quattrocchi E, Howland MA. Severe hyperthermia secondary to intravenous drug abuse. Am J Emerg Med. 1984;2:373.PubMedCrossRefGoogle Scholar
  55. 55.
    Loghmanee F, Tobak M. Fatal malignant hyperthermia associated with recreational cocaine and ethanol abuse. Am J Forensic Med Pathol. 1986;7(3):246–248.PubMedCrossRefGoogle Scholar
  56. 56.
    Goldfrank LR, et al., eds. Toxicologic Emergencies. 3rd ed. Nor-walk, Conn: Appleton-Century-Crofts; 1986:477–486.Google Scholar
  57. 57.
    Gold MS. Medical implications of cocaine intoxication. Alcoholism and Addiction. October 1989:16.Google Scholar
  58. 58.
    Merigian KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis, and acute renal failure. J Toxicol Clin Toxicol. 1987;25:135–148.PubMedCrossRefGoogle Scholar
  59. 59.
    Krohn KD, Slowman-Kovacs S, Leapman SB. Cocaine and rhabdomyolysis. Ann Intern Med. 1988;208:639–640.Google Scholar
  60. 60.
    Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med. 1988;319(11):673–677.PubMedCrossRefGoogle Scholar
  61. 61.
    Nolte KB. Rhabdomyolysis associated with cocaine abuse. Hum Pathol. 1991;22:1141–1145.PubMedCrossRefGoogle Scholar
  62. 62.
    Schweitzer VG. Osteolytic sinusitis and pneumomediastinum: deceptive otolaryngologic complications of cocaine abuse. Laryngoscope. 1986;96:206–210.PubMedGoogle Scholar
  63. 63.
    Vilensky W. Illicit and licit drugs causing perforation of the nasal septum. J Forensic Sci. 1982;27:958–962.PubMedGoogle Scholar
  64. 64.
    Van Dyke C, Jatlow P, Ungerer J, et al. Oral cocaine: plasma concentrations and central effects. Science. 1978;200:211–213.PubMedCrossRefGoogle Scholar
  65. 65.
    Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press; 1987:1600–1603.Google Scholar
  66. 66.
    Cregler LL, Mark H. Cardiovascular dangers of cocaine abuse. Am J Cardiol. 1986;57(1):1185–1186.PubMedCrossRefGoogle Scholar
  67. 67.
    Kosten TR, Kleber HD. Sudden death in cocaine abusers: relation to neuroleptic malignant syndrome. Lancet. 1987;1(8543):1198–1199.PubMedCrossRefGoogle Scholar
  68. 68.
    Kilaru P, Kim W, Sequeira W. Cocaine and scleroderma: is there an association? J Rheumatol. 1991;18:1753–1755.PubMedGoogle Scholar
  69. 69.
    Derlet RW, Albertson TE. Emergency department presentation of cocaine intoxication. Ann Emerg Med. 1989;18(2):115–119.CrossRefGoogle Scholar
  70. 70.
    Chasnoff IJ, Griffith DR, Freier C, Murray J. Cocaine/polydrug use in pregnancy. Pediatrics. 1992;89(2):284–289.PubMedGoogle Scholar
  71. 71.
    George SK, Price J, Hauth J, Barnette DM, Preston P. Drug abuse screening of childbearing-age women in Alabama public health clinics. Am J Obstet Gynecol. 1991;165:924–927.PubMedGoogle Scholar
  72. 72.
    Woods JR Jr, Plessinger MA. Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol. 1990;162(2):529–533.PubMedGoogle Scholar
  73. 73.
    Pritchard JA, MacDonald PC, Gant NF. Williams Obstetrics. Nor-walk, Conn: Appleton-Century-Crofts; 1985:395–407.Google Scholar
  74. 74.
    Finnegan L. The dilemma of cocaine exposure in the perinatal period. Natl Inst Drug Abuse Res Monogr Ser. 1988;81:379.Google Scholar
  75. 75.
    Richards IS, Kulkarni AP, Remner WF. Cocaine-induced arrhythmia in human foetal myocardium in vitro: possible mechanism for foetal death in utero. Pharmacol Toxicol. 1990;66:150–154.PubMedCrossRefGoogle Scholar
  76. 76.
    Tabor BL, Soffici AR, Smith-Wallace T, Yonekura ML. The effect of maternal cocaine use on the fetus: changes in antepartum fetal heart rate tracings. Am J Obstet Gynecol. 1991;165:1278–1281.PubMedGoogle Scholar
  77. 77.
    Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics. 1989;84(2):205–210.PubMedGoogle Scholar
  78. 78.
    Critchley HOD, Woods SM, Barson AJ, et al. Fetal death in utero and cocaine abuse. Case report. Br J Obstet Gynecol. 1988;95:195–196.CrossRefGoogle Scholar
  79. 79.
    Bateman DA, Heagarty MC. Passive freebase cocaine (“crack”) inhilation by infants and toddlers. Am J Dis Child. 1989; 134(1):25–27.Google Scholar
  80. 80.
    Dobersczak TM, Shanzer S, Senie RT, Kandall SR. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr. 1988;113(2):354–358.CrossRefGoogle Scholar
  81. 81.
    Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320(12):762–768.PubMedCrossRefGoogle Scholar
  82. 82.
    Newald J. Cocaine infants: a new arrival at hospital’s step? Hospitals. 1986;60(7):96.Google Scholar
  83. 83.
    Astley SJ, Clarren SK, Little RE, Sampson PD, Daling JR. Analysis of facial shape in children gestationally exposed to marijuana, alcohol, and/or cocaine. Pediatrics. 1992;89:67–77.PubMedGoogle Scholar
  84. 84.
    Ward SLD, Schuetz S, Krishna V, et al. Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers. Am J Dis Child. 1986;140:1015–1020.PubMedGoogle Scholar
  85. 85.
    Chasnoff IJ. Perinatal effects of cocaine. Contemp OB/GYN. May 1987:163–179.Google Scholar
  86. 86.
    Chasnoff IJ. Cocaine intoxication in an infant via maternal milk. Pediatrics. In press.Google Scholar
  87. 87.
    Infants, children test positive for cocaine after exposure to second-crack smoke. JAMA Med News Perspect. 1992;267(8):1044–1045.Google Scholar
  88. 88.
    Gold MS. 1988 Medical and Health Annual. Chicago: Encyclopaedia Britannica, Inc; 1988:277–284.Google Scholar
  89. 89.
    Weiss RD, Mirin SM, Michael JL, Sollogub AC. Psychopath-ology in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1986;12:17–29.PubMedCrossRefGoogle Scholar
  90. 90.
    Gold MS. The Good News About Panic, Anxiety, and Phobias. New York: Villard Books; 1989.Google Scholar
  91. 91.
    Post RM, Weiss SB, Pert A. Sensitization and kindling effects of chronic cocaine administration. In: Lakowski JM, Galloway MP, Ehite FJ, eds. Cocaine: Pharmacology, Physiology, and Clinical Strategies. Boca Raton, Fla: CRC Press; 1992:chap 7.Google Scholar
  92. 92.
    Post R. Talk given at the ASAM’s 23rd Annual Medical-Scientific Conference. Washington, DC; April 2-5, 1992.Google Scholar
  93. 93.
    Saravey SM, Marie J, Steinberg MD, Rabiner CJ. “Doom anxiety” and delirium in lidocaine toxicity. Am J Psychiatry. 1986;144:159.Google Scholar
  94. 94.
    Siegel RK. Cocaine smoking disorders: diagnosis and treatment. Psychiatric Ann. 1984;14(10):728–732.Google Scholar
  95. 95.
    Hudson JI, Weiss RD, Pope HG, McElroy SK, Mirin SM. Eating disorders in hospitalized substance abusers. Am J Drug Alcohol Abuse. 1992;18(1):75–85.PubMedCrossRefGoogle Scholar
  96. 96.
    Katz JL, Terry P, Witkin JM. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sci. 1992;50:1351–1361.PubMedCrossRefGoogle Scholar
  97. 97.
    Randall T. Cocaine, alcohol, mix in body to form even longer lasting, more lethal drug. JAMA. 1992;267(6):1043–1044.PubMedCrossRefGoogle Scholar
  98. 98.
    Verebey K, Gold MS. From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psychiatric Ann. 1988;18(9):513–521.Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • Mark S. Gold
    • 1
  1. 1.Departments of Neuroscience and PsychiatryUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations